鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/05/13 | 4,015 | 4,015 | 3,945 | 3,955 | -60 | -1.5% | 10,100 |
| 2024/05/10 | 4,035 | 4,080 | 4,010 | 4,015 | -20 | -0.5% | 19,400 |
| 2024/05/09 | 3,975 | 4,035 | 3,970 | 4,035 | +60 | +1.5% | 8,200 |
| 2024/05/08 | 3,950 | 4,010 | 3,950 | 3,975 | -10 | -0.3% | 22,900 |
| 2024/05/07 | 4,015 | 4,015 | 3,930 | 3,985 | +25 | +0.6% | 25,800 |
| 2024/05/02 | 3,995 | 4,035 | 3,960 | 3,960 | -15 | -0.4% | 20,600 |
| 2024/05/01 | 3,945 | 4,015 | 3,935 | 3,975 | +30 | +0.8% | 23,000 |
| 2024/04/30 | 3,850 | 4,005 | 3,785 | 3,945 | +90 | +2.3% | 82,400 |
| 2024/04/26 | 3,790 | 3,880 | 3,760 | 3,855 | +65 | +1.7% | 48,200 |
| 2024/04/25 | 3,785 | 3,830 | 3,765 | 3,790 | +30 | +0.8% | 39,500 |
| 2024/04/24 | 3,820 | 3,820 | 3,730 | 3,760 | -20 | -0.5% | 18,900 |
| 2024/04/23 | 3,800 | 3,805 | 3,755 | 3,780 | +15 | +0.4% | 14,900 |
| 2024/04/22 | 3,745 | 3,780 | 3,705 | 3,765 | +75 | +2% | 20,100 |
| 2024/04/19 | 3,765 | 3,765 | 3,645 | 3,690 | -85 | -2.3% | 22,300 |
| 2024/04/18 | 3,695 | 3,790 | 3,650 | 3,775 | +110 | +3% | 44,900 |
| 2024/04/17 | 3,780 | 3,780 | 3,655 | 3,665 | -125 | -3.3% | 40,000 |
| 2024/04/16 | 3,860 | 3,875 | 3,785 | 3,790 | -105 | -2.7% | 26,500 |
| 2024/04/15 | 3,910 | 3,935 | 3,870 | 3,895 | -55 | -1.4% | 26,400 |
| 2024/04/12 | 3,975 | 3,990 | 3,950 | 3,950 | -25 | -0.6% | 15,600 |
| 2024/04/11 | 3,990 | 4,000 | 3,935 | 3,975 | -55 | -1.4% | 32,500 |
| 2024/04/10 | 4,010 | 4,040 | 4,010 | 4,030 | +20 | +0.5% | 5,200 |
| 2024/04/09 | 4,065 | 4,065 | 3,995 | 4,010 | -40 | -1% | 18,700 |
| 2024/04/08 | 4,070 | 4,075 | 4,010 | 4,050 | +20 | +0.5% | 14,800 |
| 2024/04/05 | 4,000 | 4,050 | 3,990 | 4,030 | +5 | +0.1% | 17,900 |
| 2024/04/04 | 4,070 | 4,080 | 4,005 | 4,025 | -85 | -2.1% | 34,100 |
| 2024/04/03 | 4,045 | 4,130 | 4,030 | 4,110 | +45 | +1.1% | 57,600 |
| 2024/04/02 | 4,140 | 4,140 | 4,020 | 4,065 | -45 | -1.1% | 41,100 |
| 2024/04/01 | 4,140 | 4,160 | 4,090 | 4,110 | +15 | +0.4% | 28,000 |
| 2024/03/29 | 4,115 | 4,115 | 4,060 | 4,095 | -20 | -0.5% | 16,400 |
| 2024/03/28 | 4,125 | 4,175 | 4,080 | 4,115 | -20 | -0.5% | 20,600 |
| 2024/03/27 | 4,050 | 4,155 | 4,050 | 4,135 | +135 | +3.4% | 35,700 |
| 2024/03/26 | 3,990 | 4,035 | 3,990 | 4,000 | -10 | -0.2% | 13,700 |
| 2024/03/25 | 3,990 | 4,040 | 3,950 | 4,010 | ±0 | ±0% | 38,700 |
| 2024/03/22 | 4,075 | 4,075 | 3,995 | 4,010 | -70 | -1.7% | 44,100 |
| 2024/03/21 | 4,140 | 4,170 | 4,070 | 4,080 | -55 | -1.3% | 29,700 |
| 2024/03/19 | 4,210 | 4,210 | 4,100 | 4,135 | -75 | -1.8% | 21,300 |
| 2024/03/18 | 4,235 | 4,285 | 4,210 | 4,210 | -20 | -0.5% | 21,800 |
| 2024/03/15 | 4,245 | 4,270 | 4,215 | 4,230 | -30 | -0.7% | 16,300 |
| 2024/03/14 | 4,295 | 4,295 | 4,195 | 4,260 | -5 | -0.1% | 16,400 |
| 2024/03/13 | 4,285 | 4,290 | 4,215 | 4,265 | -15 | -0.4% | 11,300 |
| 2024/03/12 | 4,315 | 4,315 | 4,205 | 4,280 | -35 | -0.8% | 21,500 |
| 2024/03/11 | 4,300 | 4,315 | 4,255 | 4,315 | -5 | -0.1% | 21,100 |
| 2024/03/08 | 4,220 | 4,370 | 4,220 | 4,320 | +55 | +1.3% | 39,300 |
| 2024/03/07 | 4,290 | 4,310 | 4,235 | 4,265 | -10 | -0.2% | 17,500 |
| 2024/03/06 | 4,225 | 4,300 | 4,215 | 4,275 | +95 | +2.3% | 30,500 |
| 2024/03/05 | 4,160 | 4,195 | 4,080 | 4,180 | ±0 | ±0% | 22,800 |
| 2024/03/04 | 4,210 | 4,260 | 4,170 | 4,180 | -15 | -0.4% | 28,600 |
| 2024/03/01 | 4,300 | 4,305 | 4,180 | 4,195 | -65 | -1.5% | 40,500 |
| 2024/02/29 | 4,220 | 4,285 | 4,205 | 4,260 | +60 | +1.4% | 36,200 |
| 2024/02/28 | 4,300 | 4,330 | 4,200 | 4,200 | -5 | -0.1% | 60,300 |
251～
300
件表示中 / 3703件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| サワイＧＨＤ | 176,100円 | +5.9% | +24.5% | 3.12% | 11.68倍 | 1.10倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 389,000円 | +3.6% | +6.1% | 3.08% | 13.10倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 科研薬 | 372,000円 | -6.4% | -71.8% | 5.11% | 41.43倍 | 0.92倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 296,700円 | +7.9% | -3.3% | 2.70% | 8.25倍 | 0.85倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
